PF-04991532

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePF-04991532
Drug Alias NamePF-4991532PF-04991532
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucokinase activators
TargetsGlucokinase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes MellitusGlucose Metabolism Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes MellitusGlucose Metabolism Disorders

Other Information

ATC CodeN/A
Related LinksN/A